CANDRA SMITH: Open Payments
NPI 1851945638 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,314 in 56 payments from 11 companies in 2025. Trend: 2023 $1,419 · 2024 $889 · 2025 $1,314
Food & beverage: $1,314
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 27 | $498 |
| Axsome Therapeutics, Inc. | 10 | $366 |
| Otsuka America Pharmaceutical, Inc. | 8 | $171 |
| ABBVIE INC. | 3 | $73 |
| Corium, LLC | 2 | $64 |
| Janssen Pharmaceuticals, Inc | 1 | $32 |
| Lundbeck LLC | 1 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Luye Pharma (USA) Ltd. | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
Products named: ARISTADA, Auvelity, ABILIFY MAINTENA, VRAYLAR, Azstarys, ABILIFY ASIMTUFII, SPRAVATO, REXULTI.
Industry payments across TX — which companies pay providers there.
